Dihydroxyindoline HBr COA and Purity Verification: Ensuring Industrial-Grade Quality for Pharmaceutical Intermediates
- Comprehensive COA parameters validate ≥95% purity of 5,6-Dihydroxyindoline hydrobromide (C8H10BrNO2) for pharmaceutical use.
- Multi-method analytical verification (HPLC, NMR, LC-MS) ensures batch-to-batch consistency in the manufacturing process.
- NINGBO INNO PHARMCHEM CO.,LTD. supplies bulk quantities with full documentation, including COA, MSDS, and spectral data.
In the competitive landscape of fine chemical intermediates, quality assurance is non-negotiable—especially for sensitive compounds like Dihydroxyindoline HBr (CAS: 138937-28-7). As a critical building block in pharmaceutical synthesis, this compound demands rigorous purity verification and transparent Certificate of Analysis (COA) documentation. Buyers sourcing high-purity Dihydroxyindoline HBr must prioritize suppliers with robust quality control systems, advanced analytical capabilities, and consistent industrial-scale production.
Understanding Certificate of Analysis (COA) Parameters
A valid COA for 5,6-Dihydroxyindoline hydrobromide must go beyond a simple purity percentage. Reputable manufacturers provide a detailed breakdown of critical quality attributes, including:
- Assay (Purity): Typically reported as 85.0–99.8%, though pharmaceutical applications often require ≥95%.
- Residual Solvents: Quantified via GC to ensure compliance with ICH Q3C guidelines.
- Heavy Metals: Tested per USP <231> or EP 2.4.8, with limits usually ≤10 ppm.
- Water Content: Measured by Karl Fischer titration to confirm stability during storage.
- Appearance & Physical State: White to off-white crystalline powder under standard conditions.
At NINGBO INNO PHARMCHEM CO.,LTD., every batch of C8H10BrNO2 undergoes full-spectrum validation before release. The COA is not a static document—it reflects real-time data from in-process controls and final product testing, ensuring traceability and regulatory readiness.
Analytical Methods for Verifying ≥95% Purity
Purity claims without methodological transparency are commercially risky. Leading manufacturers employ orthogonal analytical techniques to cross-verify results. For Dihydroxyindoline HBr, the following methods are standard:
| Method | Purpose | Typical Specification |
|---|---|---|
| HPLC (High-Performance Liquid Chromatography) | Quantify main peak area % | ≥95.0% (UV detection at 280 nm) |
| 1H-NMR | Confirm molecular structure & detect isomers | Characteristic indoline ring protons at δ 6.5–7.2 ppm |
| LC-MS (Liquid Chromatography-Mass Spectrometry) | Verify molecular ion [M+H]+ | m/z = 156.0 (free base); 232.0 for C8H10BrNO2 |
| Karl Fischer Titration | Measure water content | ≤1.0% |
This multi-platform approach eliminates false positives and ensures that impurities—such as regioisomers or residual brominating agents—are detected at ppm levels. Such rigor is essential for clients developing APIs where even minor contaminants can derail clinical trials.
Batch Consistency and Quality Control Protocols
Consistent quality across batches is a hallmark of a mature manufacturing process. NINGBO INNO PHARMCHEM CO.,LTD. maintains ISO 9001:2015-certified facilities with dedicated QC labs that enforce strict in-process checks during the synthesis route of 5,6-Dihydroxyindoline hydrobromide. Key protocols include:
- Raw Material Qualification: All starting materials are tested against internal and pharmacopeial standards.
- Reaction Monitoring: In-situ FTIR or HPLC tracks conversion efficiency and byproduct formation.
- Crystallization Control: Optimized solvent systems ensure high crystal purity and reproducible particle size.
- Stability Testing: Accelerated studies (40°C/75% RH) confirm shelf life under recommended storage conditions (cool, dry, sealed).
With a production capacity of 10 metric tons per month, the company guarantees supply continuity without compromising on industrial purity. Every shipment includes a complete dossier: COA, MSDS, H-NMR, HPLC chromatograms, and certificates of origin—enabling seamless regulatory submissions worldwide.
Why Global Buyers Trust NINGBO INNO PHARMCHEM CO.,LTD.
As a premier global manufacturer of specialty intermediates, NINGBO INNO PHARMCHEM CO.,LTD. combines technical excellence with commercial reliability. Their commitment to “quality control as life” translates into:
- Full analytical transparency beyond basic COA
- Flexible packaging (100g to 25kg drums) and global logistics (air, sea, express)
- OEM/ODM support and rapid response within 12 hours
- Competitive bulk price without sacrificing assay integrity
For R&D labs and API producers requiring verified, high-purity Dihydroxyindoline HBr, partnering with a manufacturer that embeds quality into every step of the synthesis route is not just advisable—it’s essential.